NCT02721875View on ClinicalTrials.gov

Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes

PHASE1TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 28, 2016

Primary Completion Date

June 29, 2016

Study Completion Date

July 29, 2016

Conditions
Myelodysplastic Syndromes
Interventions
DRUG

Volasertib

DRUG

Volasertib

DRUG

Azacitidine

Trial Locations (1)

910-1193

University of Fukui Hospital, Fukui, Yoshida-gun

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02721875 - Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes | Biotech Hunter | Biotech Hunter